@article{ATM19456,
author = {Yong-Lei Gao and Nan Wang and Fu-Rong Sun and Xi-Peng Cao and Wei Zhang and Jin-Tai Yu},
title = {Tau in neurodegenerative disease},
journal = {Annals of Translational Medicine},
volume = {6},
number = {10},
year = {2018},
keywords = {},
abstract = {Tau, a microtubule-associated protein, is the main component of the intracellular filamentous inclusions that are involved in neurodegenerative diseases known as tauopathies, including Alzheimer disease (AD), frontotemporal dementia with parkinsonism-17 (FTDP-17), Pick disease (PiD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Hyperphosphorylated, aggregated tau proteins form the core of neurofibrillary tangles (NFTs), which are shown to be one of the pathological hallmarks of AD. The discovery of mutations in the microtubule-associated protein tau (MAPT) gene in patients with FTDP-17 also contributes to a better understanding of the dysfunctional tau as a cause of diseases. Although recent substantial progress has been made in the tau pathology of tauopathies, the mechanisms underlying tau-induced neurodegeneration remain unclear. Here, we present an overview of the biochemical properties of tau protein and the pathogenesis underlying tau-induced neurodegenerative diseases. Meanwhile, we will discuss the tau-related biomarkers and ongoing tau-targeted strategies for therapeutic modulation.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/19456}
}